Q3 2020 Inovio Pharmaceuticals Inc Earnings Call Transcript
Good day and welcome to the Inovio Pharmaceuticals Third Quarter 2020 Financial Results Conference Call. (Operator Instructions) Please note this event is being recorded.
I would now like to turn the conference over to Ben Matone. Please go ahead.
Thank you, operator. Good afternoon and thank you for joining the Inovio Third Quarter 2020 Earnings Conference Call. With us today are Dr. Joseph Kim, President and CEO; Dr. Jacqueline Shea, Inovio's Chief Operating Officer; the company's Chief Financial Officer, Peter Kies; Dr. Prakash Bhuyan, Vice President of Clinical Development and Head of Inovio's Clinical Programs to treat HPV-related precancers; and Dr. Kate Broderick, Senior Vice President of Research and Development.
This call is being webcast live on our website, ir.inovio.com, and a replay will be made available as indicated in today's press release. For today's call, we will review our corporate and financial information for the third quarter 2020 ended September 30, 2020, as
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |